Dr. Douglas Lienesch, MD

Dr. Lienesch practices at CCHS Rheumatology in Newark, Delaware.

Dr. Lienesch's NPI, 1124129747, was assigned on September 26, 2006. Dr. Lienesch holds Delaware license C1-0013313.

Dr. Lienesch's primary practice is CCHS Rheumatology, at 4735 Ogletown Stanton Rd, Newark, DE 19713 in New Castle County. The practice phone is (302) 428-2522.

Dr. Lienesch's primary practice is CCHS Rheumatology in Newark, Delaware. Dr. Lienesch is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Dr. Lienesch to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lienesch practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Lienesch's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Lienesch is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Lienesch's licenses on file in 2 states: Delaware and Pennsylvania.

CMS data shows 797 Medicare services from Dr. Lienesch across 8 procedure codes in 2024, for 529 Medicare patients. Medicare paid $62,550 for them.

CMS counts 529 Medicare patients who saw Dr. Lienesch in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have arthritis, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lienesch's median patient age at 68, with 77% women.

In 2024, Dr. Lienesch wrote 2,976 Medicare Part D claims for 479 patients. 86% of them were for generic drugs. CMS names the drug for 2,761 of them, across 50 drugs with 11 or more claims each, at $2,000,897 in total drug cost. In 2023, CMS named 2,147 claims across 40 drugs.

Dr. Lienesch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lienesch as offering telehealth.

Dmand AI links 4 papers to Dr. Lienesch. The most frequent topics are Arthritis, Rheumatoid and Cryoglobulinemia. Dr. Lienesch's most frequent co-authors are Rohit Aggarwal, MD and Jeremy Scott Tilstra, MD, PhD.

CMS Open Payments shows 22 general payments to Dr. Lienesch from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Amgen Inc. paid the most, $285.